Cibc Private Wealth Group, LLC Axsome Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 16,394 shares of AXSM stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,394
Previous 17,999
8.92%
Holding current value
$1.29 Million
Previous $1.43 Million
8.66%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$355 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$295 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$252 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$186 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$103 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.38B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...